BioSpace News Archive

Business

AbbVie Declares Quarterly Dividend - Sep 11, 2020

The board of directors of AbbVie Inc. declared a quarterly cash dividend of $1.18 per share.

September 11, 2020
·
1 min read
M-LIFE™ RELEASES TOXICITY PREDICTIONS FOR COVID-19 DRUGS

M-LIFE™ has predicted the toxicity profiles across multiple organ systems for a variety of prospective re-purposed COVID-19 drugs.

September 11, 2020
·
4 min read
Deals

Guardion Announces Virtual Annual Meeting of Stockholders - Sep 11, 2020

Guardion Health Sciences, Inc. announced that due to the public health concerns related to COVID-19 and to support the health and safety of its stockholders, employees and communities, it will provide virtual attendance at its 2020 Annual Meeting of Stockholders.

September 11, 2020
·
4 min read
Haoma Medica Announces Plenary Presentation for NaQuinate, a Potential Novel Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting

Haoma Medica announced a presentation made today at the 2020 American Society for Bone and Mineral Research:

September 11, 2020
·
2 min read
Deals

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 11, 2020

Mirum Pharmaceuticals, Inc. announced that on September 10, 2020, the Compensation Committee of Mirum’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 103,700 shares of common stock to five new employees under Mirum’s 2020 Inducement Plan.

September 11, 2020
·
2 min read
Policy

American Diabetes Association Applauds the Ending Health Disparities during COVID-19 (EHDC) Act

The bill from Rep. Robin Kelly (D-IL) extends protections to low-income and minority communities during COVID-19

September 11, 2020
·
4 min read
Business

Experion Announces Chief Financial Officer Change

Experion Holdings Ltd. (the “Company” or “Experion”) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) announced today that its Chief Financial Officer Kamini Hitkari has advised the Company of her decision to resign from the Company to pursue another opportunity.

September 11, 2020
·
2 min read
Major ‘plasmaMATCH’ trial uses blood test to match women with breast cancer to range of precision treatments

A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal.

September 11, 2020
·
8 min read
Resverlogix Provides Update Regarding Extension of its Filing CalendarConfirms Annual Filings on SEDAR

Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announces that it has filed its annual financial statements for the year ended April 30, 2020, related MD&A and annual information form pursuant to National Instrument 51-102 (collectively, the “Annual Filings”).

September 11, 2020
·
4 min read
Biotech Beach

Coronavirus Breakthrough: Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient - Discharged Following Five Days of Treatment

Senhwa Biosciences, Inc. (TPEx: 6492), announced today that the first patient with severe COVID-19 demonstrated remarkable recovery after treatment with the Company’s investigational drug, Silmitasertib.

September 11, 2020
·
3 min read